Insiders Anthera Pharmaceuticals, Inc.

Equities

ANTH

US03674U3005

Delayed OTC Markets Other stock markets 01:20:58 25/04/2024 am IST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-98.51%

2018	Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index	CI
2018	Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anthera Pharmaceuticals, Inc. Appoints Patrick Murphy as Senior Vice President, Manufacturing	03/18/03	CI
Anthera Pharmaceuticals, Inc. Announces Executive Changes	15/17/15	CI
Anthera Pharmaceuticals Announces Resignation of Klara Dickinson-Eason as Senior Vice President, Chief Regulatory Officer, Effective June 20, 2017	20/17/20	CI
Steven Engle Retires from the Board of Directors of Anthera Pharmaceuticals, Inc	28/17/28	CI
Anthera Pharmaceuticals, Inc. Announces Executive Changes	07/16/07	CI
Anthera Pharmaceuticals, Inc. Announces Executive Changes	17/16/17	CI
Anthera Pharmaceuticals Announces Board Changes	28/16/28	CI
Anthera Pharmaceuticals, Inc. Announces Executive Changes, Effective April 1, 2016	07/16/07	CI
Anthera Pharmaceuticals, Inc. Announces Executive Appointments	06/16/06	CI
Anthera Pharmaceuticals Announces Appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer	08/15/08	CI
Anthera Pharmaceuticals, Inc. Announces the Appointment of Chuck Olson as President	15/14/15	CI
Anthera Pharmaceuticals Announces Board Changes	24/14/24	CI
Anthera Pharmaceuticals, Inc. Announces Board Changes	14/14/14	CI
Anthera Pharmaceuticals, Inc. Announces Board Changes	01/14/01	CI
Anthera Pharmaceuticals Announces Board Changes	01/14/01	CI
Anthera Pharmaceuticals, Inc. Announces Executive Changes	13/13/13	CI
Anthera Pharmaceuticals, Inc. Announces Management Changes	18/13/18	CI
Anthera Pharmaceuticals, Inc. Appoints Sanford Zweifach as Class I Director	27/13/27	CI
Anthera Pharmaceuticals Announces Departure of Senior Vice President of Product Development, Georgina Kilfoil	05/13/05	CI
Donald Santel Resigns from Board of Directors of Anthera Pharmaceuticals, Inc	09/12/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Anthera Pharmaceuticals, Inc.

Equities

ANTH

US03674U3005

Insiders

Filters